Delving into the Latest Updates on Qinghai Pulante Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Immune System Diseases

Respiratory Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Immune System Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

To explore the safe and effective dose of Pingfeng Bishu Capsule for the treatment of perennial allergic rhinitis (lung deficiency and cold syndrome), to evaluate the efficacy and safety of Pingfeng Bishu Capsule for the treatment of perennial allergic rhinitis (lung deficiency and cold syndrome), and to provide a basis for the formulation of Phase III clinical trial plan.

Start Date25 Mar 2014

Sponsor / Collaborator

Qinghai Pulante Pharmaceutical Co., Ltd.

100 Clinical Results associated with Qinghai Pulante Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Qinghai Pulante Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Qinghai Pulante Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Qinghai Pulante Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data